$6.09
2.35% day before yesterday
Nasdaq, Dec 24, 10:13 pm CET
ISIN
US71535D1063
Symbol
PSNL
Sector
Industry

Personalis Inc Stock price

$6.09
+2.49 69.17% 1M
+4.88 403.31% 6M
+3.99 190.00% YTD
+4.63 315.70% 1Y
-7.52 55.25% 3Y
-3.75 38.11% 5Y
-10.91 64.18% 10Y
Nasdaq, Closing price Wed, Dec 25 2024
+0.00 0.00%
ISIN
US71535D1063
Symbol
PSNL
Sector
Industry

Key metrics

Market capitalization $432.51m
Enterprise Value $334.02m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.82
P/S ratio (TTM) P/S ratio 4.94
P/B ratio (TTM) P/B ratio 2.58
Revenue growth (TTM) Revenue growth 24.05%
Revenue (TTM) Revenue $87.49m
EBIT (operating result TTM) EBIT $-70.09m
Free Cash Flow (TTM) Free Cash Flow $-54.65m
Cash position $143.65m
EPS (TTM) EPS $-1.68
P/E forward negative
P/S forward 5.19
EV/Sales forward 4.00
Short interest 6.54%
Show more

Is Personalis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,885 stocks worldwide.

Personalis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Personalis Inc forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Personalis Inc forecast:

Buy
83%
Hold
17%

Financial data from Personalis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
87 87
24% 24%
100%
- Direct Costs 60 60
9% 9%
69%
27 27
79% 79%
31%
- Selling and Administrative Expenses 35 35
18% 18%
40%
- Research and Development Expense 51 51
25% 25%
58%
-59 -59
38% 38%
-67%
- Depreciation and Amortization 11 11
15% 15%
13%
EBIT (Operating Income) EBIT -70 -70
35% 35%
-80%
Net Profit -91 -91
19% 19%
-105%

In millions USD.

Don't miss a Thing! We will send you all news about Personalis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Personalis Inc Stock News

Neutral
Business Wire
7 days ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and Moderna that accelerate the advancement of the company's business strategy. The company has received an investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Moderna to utilize Personalis' Im...
Neutral
Business Wire
10 days ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL) and Tempus AI, Inc. (Nasdaq: TEM) announced today that the companies have expanded their commercial relationship. The companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus is servin...
Neutral
Business Wire
about one month ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will participate at the following investor conferences: Piper Sandler 36th Annual Healthcare Conference Date: Tuesday, December 3, 2024 Fireside Chat Time: 12:30 pm Eastern Time Location: The Lotte New York Palace in New York, NY TD Co...
More Personalis Inc News

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christopher Hall
Employees 225
Founded 2011
Website www.personalis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today